Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 1, 2016, Pages 82.e1-82.e11

  Coleman, Robert L ^a   Herzog, Thomas J ^b   Chan, Daniel W ^c   Munroe, Donald G ^d   Pappas, Todd C ^d   Smith, Alan ^e   Zhang, Zhen ^c   Wolf, Judith ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Vermillion Inc   (United States)

^e Applied Clinical Intelligence LLC   (United States)

Author keywords

diagnostic; ovarian cancer; protein; referral; serum

Indexed keywords

APOLIPOPROTEIN A1; CA 125 ANTIGEN; FOLLITROPIN; HUMAN EPIDIDYMIS PROTEIN 4; TRANSFERRIN; TUMOR MARKER;

ADNEXA DISEASE; ADULT; ANALYZER; ARTICLE; ASSAY; BENIGN TUMOR; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CLINICAL LABORATORY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY CANCER; EARLY CANCER DIAGNOSIS; ETHNICITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; MIDDLE AGED; OVARY CANCER; PELVIS TUMOR; POSTMENOPAUSE; PREDICTIVE VALUE; PREMENOPAUSE; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; SECOND GENERATION MULTIVARIATE INDEX ASSAY; SENSITIVITY AND SPECIFICITY; SURGICAL PATIENT; VALIDATION STUDY; ADNEXAL DISEASES; ALGORITHM; BLOOD; CLINICAL TRIAL; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; REGISTER; RISK ASSESSMENT;

ADNEXAL DISEASES; ADULT; ALGORITHMS; BIOMARKERS, TUMOR; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84964394146     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.03.003     Document Type: Article

References (27)

1. J.E. Dodge, A.L. Covens, C. Lacchetti, and et al. Management of a suspicious adnexal mass: a clinical practice guideline Curr Oncol 19 2012 e244 e257
2. American College of Obstetricians and Gynecologists The role of the generalist obstetrician gynecologist in the early detection of epithelial ovarian cancer. ACOG Committee opinion no. 280 Obstet Gynecol 117 2011 742 746
3. American College of Obstetricians and Gynecologists The role of the generalist obstetrician gynecologist in the early detection of ovarian cancer. ACOG Committee opinion no. 280 Obstet Gynecol 100 2002 1413 1416
4. L. McGowan, L.P. Lesher, H.J. Norris, and M. Barnett Misstaging of ovarian cancer Obstet Gynecol 65 1985 568 572
5. K.C. Giede, K. Kieser, J. Dodge, and B. Rosen Who should operate on patients with ovarian cancer? An evidence-based review Gynecol Oncol 99 2005 447 461
6. M.E. Carney, J.M. Lancaster, C. Ford, A. Tsodikov, and C.L. Wiggins A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol 84 2002 36 42
7. F.R. Ueland, C.P. Desimone, L.G. Seamon, and et al. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors Obstet Gynecol 117 2011 1289 1297
8. R.E. Bristow, A. Smith, Z. Zhang, and et al. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay Gynecol Oncol 128 2013 252 259
9. A.C. Dearking, G.D. Aletti, M.E. McGree, A.L. Weaver, M.K. Sommerfield, and W.A. Cliby How relevant are ACOG and SGO guidelines for referral of adnexal mass? Obstet Gynecol 110 2007 841 848
10. R.E. Bristow, M. Hodeib, A. Smith, and et al. Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass Am J Obstet Gynecol 209 2013 581.e1 581.e8
11. Z. Zhang, R.C. Bast Jr., Y. Yu, and et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res 64 2004 5882 5890
12. Z. Zhang, and D.W. Chan The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers Cancer Epidemiol Biomarkers Prev 19 2010 2995 2999
13. Z.P. Zhang, G. Page, and H. Zhang Applying classification separability analysis to microarray data S.M. Lin, K.J. Johnson, Methods of microarray data analysis 2001 Kluwer Academic Publishers Boston (MA)
14. E.B. Wilson Probable inference, the law of succession, and statistical inference J Am Stat Assoc 22 1927 209 212
15. C.S. Moskowitz, and M.S. Pepe Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs Clin Trials 3 2006 272 279
16. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
17. Z. Feng, J. Kagan, M. Pepe, and et al. The early detection research network's specimen reference sets: paving the way for rapid evaluation of potential biomarkers Clin Chem 59 2013 68 74
18. T.C. Longoria, F.R. Ueland, Z. Zhang, and et al. Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer Am J Obstet Gynecol 210 2014 78.e1 78.e9
19. American Cancer Society Cancer facts and figures 2015 2015 American Cancer Society Atlanta (GA)
20. Society of Gynecologic Oncology SGO position statement. Multiplex serum testing for women with pelvic mass 2013 Society of Gynecologic Oncology Chicago (IL)
21. D. Timmerman, B. Van Calster, A.C. Testa, and et al. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group Ultrasound Obstet Gynecol 36 2010 226 234
22. S.T. Goodrich, R.E. Bristow, J.T. Santoso, and et al. The effect of ovarian imaging on the clinical interpretation of a multivariate index assay Am J Obstet Gynecol 211 2014 65.e1 65.e11
23. R.E. Bristow, M.L. Zahurak, C.J. Alexander, R.C. Zellars, and F.J. Montz FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival Int J Gynecol Cancer 13 2003 664 672
24. B.A. Goff, B.J. Matthews, E.H. Larson, and et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer Cancer 109 2007 2031 2042
25. R.E. Bristow, B.E. Palis, D.S. Chi, and W.A. Cliby The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm Gynecol Oncol 118 2010 262 267
26. C. Mercado, D. Zingmond, B.Y. Karlan, and et al. Quality of care in advanced ovarian cancer: the importance of provider specialty Gynecol Oncol 117 2010 18 22
27. R.E. Bristow, J. Chang, A. Ziogas, and H. Anton-Culver Adherence to treatment guidelines for ovarian cancer as a measure of quality care Obstet Gynecol 121 2013 1226 1234